Greytown Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,852
| Closed | -$337K | – | 72 |
|
|
2024
Q1 | $337K | Sell |
1,852
-501
| -21% | -$91.3K | 0.19% | 51 |
|
|
2023
Q4 | $365K | Hold |
2,353
| – | – | 0.19% | 50 |
|
|
2023
Q3 | $351K | Sell |
2,353
-2,089
| -47% | -$311K | 0.19% | 48 |
|
|
2023
Q2 | $598K | Hold |
4,442
| – | – | 0.33% | 39 |
|
|
2023
Q1 | $708K | Sell |
4,442
-91
| -2% | -$14.5K | 0.37% | 37 |
|
|
2022
Q4 | $733K | Sell |
4,533
-871
| -16% | -$141K | 0.4% | 35 |
|
|
2022
Q3 | $725K | Sell |
5,404
-820
| -13% | -$110K | 0.44% | 37 |
|
|
2022
Q2 | $953K | Sell |
6,224
-907
| -13% | -$139K | 0.54% | 30 |
|
|
2022
Q1 | $1.16M | Sell |
7,131
-4,067
| -36% | -$659K | 0.56% | 31 |
|
|
2021
Q4 | $1.52M | Sell |
11,198
-139
| -1% | -$18.8K | 0.64% | 27 |
|
|
2021
Q3 | $1.22M | Sell |
11,337
-758
| -6% | -$81.8K | 0.54% | 41 |
|
|
2021
Q2 | $1.36M | Buy |
12,095
+3,797
| +46% | +$428K | 0.66% | 23 |
|
|
2021
Q1 | $898K | Buy |
8,298
+464
| +6% | +$50.2K | 0.45% | 40 |
|
|
2020
Q4 | $839K | Buy |
7,834
+2,397
| +44% | +$257K | 0.58% | 26 |
|
|
2020
Q3 | $476K | Sell |
5,437
-954
| -15% | -$83.5K | 0.39% | 45 |
|
|
2020
Q2 | $627K | Sell |
6,391
-3,540
| -36% | -$347K | 0.58% | 25 |
|
|
2020
Q1 | $757K | Sell |
9,931
-2,247
| -18% | -$171K | 0.75% | 28 |
|
|
2019
Q4 | $1.08M | Sell |
12,178
-150
| -1% | -$13.3K | 0.76% | 25 |
|
|
2019
Q3 | $933K | Buy |
12,328
+1,439
| +13% | +$109K | 0.69% | 29 |
|
|
2019
Q2 | $792K | Buy |
+10,889
| New | +$792K | 0.57% | 41 |
|